#INSOMNIA CURES EARTH CLINIC TRIAL#

“It also might be that quality sleep is associated with marijuana use,” Hoyos told Cosmos Weekly. The Walsh review followed breadcrumbs about a lack of dreaming which might indicate less REM sleep, but again, didn’t find strong evidence either way. We’re now using it at a pharmaceutical grade.” Camilla Hoyos There was a lot of early work with certain cannabinoids but they were so long ago often they were looking at people who smoked a lot of cannabis.

#INSOMNIA CURES EARTH CLINIC TRIAL#

Woolcock sleep researcher Dr Camilla Hoyos is working on the Bod trial and says it’s unclear how cannabis affects sleep. She also says the TGA quietly let it be known that if trials can show efficacy at a slightly higher dose, it might be convinced to bump up the limit for an OTC CBD medicine. Layers of bureaucratic red tape and a smaller market than expected has hampered sales – SAS B approvals have hovered around 120,000 for the last two years, compared to government estimates of 600,000 people using it in total.Īlong the way many of the charlatans, con artists and spivs have been pushed out and while pharmacy-only CBD is the latest medical cannabis gold rush, the proof hurdle is too high for all bar the moneyed and most serious to attempt entry. It still hasn’t hit the $100 million market size that, in 2016, financial services broker Cannacord Genuity expected it to be by 2020.

Medical cannabis has only been around in Australia since 2016, when the federal government changed the law to enable the birth of a pharmaceutical industry.īut the industry didn’t take off as expected. “In a year’s time I will look very smart and like nostradamus, or very stupid.” From THC to CBD Gavin believes the expensive Avecho trial will provide the exhaustive evidence needed to prove whether CBD does anything for sleep – or not. The hurdle to access this new market is - proof. Medical cannabis companies must prove their product actually does something, and it has to be for a condition mild enough not to need medical supervision, but not so mild it doesn’t need a drug.Īnd that cash prize? The $97 million spent on pharmacy sleep aids in 2021, and the possibility of a massive payday: the only CBD-only drug registered anywhere around the world, Epidiolex for childhood epilepsy, was bought two years ago for $US7.2 billion. The TGA’s controversial decision to allow pharmacies to sell CBD in sub-150mg doses paved the way for medical cannabis companies to bypass sceptical GP gatekeepers, and the complicated Special Access Scheme B regime, which allows them to prescribe unapproved drugs. “Which is surprising given how widely CBD is marketed for sleep in the US and Canada.”ĪSX-listed companies Cann Group, Ecofibre, Avecho and Bod Science are scrambling to be the first to medicate the 60 per cent of adult Australians who told a Sleep Health Foundation survey in 2021 they experience minor insomnia. Even at 800mg, we do not have any published data to show this is the case,” Suraev told Cosmos Weekly. “Does CBD actually help someone sleep? So far we don’t have any evidence that this is the case, even at a higher dose. “Does CBD actually help someone sleep? So far we don’t have any evidence that this is the case, even at a higher dose.” Anastasia Suraevīut there’s little compelling evidence for low dose CBD and particularly for insomnia, because CBD isn’t sedating, says Lambert Initiative for Cannabinoid Therapeutics researcher, Anastasia Suraev, who co-wrote a review paper for the regulator. Today, big cash prizes await the first registered over-the-counter (OTC) CBD drug.

But the CBD being tested is cannabidiol, a phytocannabinoid derived from Cannabis species, which is devoid of psychoactive activity, with analgesic, anti-inflammatory, antineoplastic and chemopreventive activities.Īt least four Australian companies are pursuing a low dose CBD insomnia cure after the Therapeutic Goods Administration (TGA) changed the goalposts on the cannabinoid in 2020. That’s going to surprise people who have grown up to believe that marijuana causes lethargy. Three months, three clinical trials, and three failures to beat placebo, and yet still cannabidiol (CBD) champions believe they can make low dose meds work for insomnia.

Insomnia cures earth clinic